Lane Michael D, Seelig Burckhard
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA; BioTechnology Institute, University of Minnesota, St. Paul, MN, USA.
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA; BioTechnology Institute, University of Minnesota, St. Paul, MN, USA.
Protein Expr Purif. 2016 May;121:66-72. doi: 10.1016/j.pep.2016.01.002. Epub 2016 Jan 7.
Streptococcus pyogenes produces the cysteine protease streptopain (SpeB) as a critical virulence factor for pathogenesis. Despite having first been described seventy years ago, this protease still holds mysteries which are being investigated today. Streptopain can cleave a wide range of human proteins, including immunoglobulins, the complement activation system, chemokines, and structural proteins. Due to the broad activity of streptopain, it has been challenging to elucidate the functional results of its action and precise mechanisms for its contribution to S. pyogenes pathogenesis. To better study streptopain, several expression and purification schemes have been developed. These methods originally involved isolation from S. pyogenes culture but were more recently expanded to include recombinant Escherichia coli expression systems. While substantially easier to implement, the latter recombinant approach can prove challenging to reproduce, often resulting in mostly insoluble protein and poor purification yields. After extensive optimization of a wide range of expression and purification conditions, we applied the autoinduction method of protein expression and developed a two-step column purification scheme that reliably produces large amounts of purified soluble and highly active streptopain. This method reproducibly yielded 3 mg of streptopain from 50 mL of expression culture at >95% purity, with an activity of 5306 ± 315 U/mg, and no remaining affinity tags or artifacts from recombinant expression. This improved method therefore enables the facile production of the important virulence factor streptopain at higher yields, with no purification scars that might bias functional studies, and with an 8.1-fold increased enzymatic activity compared to previously described procedures.
化脓性链球菌产生半胱氨酸蛋白酶链激酶(SpeB),这是其致病过程中的关键毒力因子。尽管该蛋白酶在七十年前就首次被描述,但至今仍存在一些谜团,目前仍在研究中。链激酶可以切割多种人类蛋白质,包括免疫球蛋白、补体激活系统、趋化因子和结构蛋白。由于链激酶的活性广泛,阐明其作用的功能结果及其对化脓性链球菌致病作用的精确机制一直具有挑战性。为了更好地研究链激酶,已经开发了几种表达和纯化方案。这些方法最初涉及从化脓性链球菌培养物中分离,但最近扩展到包括重组大肠杆菌表达系统。虽然后者的重组方法实施起来要容易得多,但事实证明很难重复,常常导致大部分蛋白质不溶且纯化产率很低。在对广泛的表达和纯化条件进行广泛优化后,我们应用了蛋白质表达的自诱导方法,并开发了一种两步柱纯化方案,该方案能够可靠地产生大量纯化的可溶性且高活性的链激酶。该方法从50 mL表达培养物中可重复获得3 mg链激酶,纯度>95%,活性为5306±315 U/mg,且没有重组表达留下的亲和标签或杂质。因此,这种改进的方法能够以更高的产率轻松生产重要的毒力因子链激酶,没有可能影响功能研究的纯化痕迹,并且与先前描述的方法相比,酶活性提高了8.1倍。